Ajooni Biotech Ltd

Ajooni Biotech Q1 FY27 Results: Net Profit ₹0.4 Cr, Down 50.0% YoY

Ajooni Biotech Ltd reported revenue from operations of ₹63.5 Cr (+102.9% YoY) and net profit of ₹0.4 Cr (-50.0% YoY) for Q1 FY27.

Key figure

Net profit ₹0.4 Cr · -50.0% YoY

Ajooni Biotech Capital Structure Change

Ajooni Biotech has allotted 90 lakh equity shares to Healthy Biosciences Limited. The total issue value is ₹3.87 Crore.

Value

₹3.87 Cr

Ajooni Biotech Board Meeting Date

Ajooni Biotech Limited has scheduled a board meeting for August 14, 2026. The board will consider and approve unaudited standalone financial results for the June 2026 quarter.

Ajooni Biotech Capital Structure Change

The company's shareholders approved an increase in its authorized share capital to ₹70 Crore at the 16th Annual General Meeting.

Ajooni Biotech Capital Structure Change

Ajooni Biotech received shareholder approval for the preferential issuance of 90,00,000 equity shares at Rs. 4.30 each, valued at approximately ₹3.87 Crore.

Value

₹3.87 Cr

Ajooni Biotech Management Change

Ajooni Biotech shareholders approved the re-appointment of Mr. Gursimran Singh as Director at the 16th Annual General Meeting held on July 29, 2026.

Ajooni Biotech Annual General Meeting

Ajooni Biotech Limited held its 16th Annual General Meeting on July 29, 2026. The meeting covered financial statements, director re-appointment, and special business items.